NCT04217733

Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome

A Comparative Study to Assess Safety and Effectiveness of Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Tanta University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Ethosuximide and pentoxifylline in the treatment of abdominal pain related to irritable bowel syndrome

Detailed description

Ethosuximide and pentoxifylline in the treatment of abdominal pain related to irritable bowel syndrome: Does this add to current treatment?

Conditions

• IBS - Irritable Bowel Syndrome

Interventions

Type	Name	Description
DRUG	pentoxyifylline	Pentoxyifylline two times daily for 3 months
DRUG	Mebeverine	Mebeverine 3 times for 3 months
DRUG	ethosuximide	ethosuximide 3 times for 3 months

Timeline

• Start date: 2019-11-01
• Primary completion: 2030-12-01
• Completion: 2030-12-30
• First posted: 2020-01-03
• Last updated: 2020-01-03

Locations

1 site across 1 country: Egypt